Patents Assigned to University
  • Patent number: 10500562
    Abstract: A passive NOX adsorbent includes: palladium, platinum or a mixture thereof and a mixed or composite oxide including the following elements in percentage by weight, expressed in terms of oxide: 10-90% by weight zirconium and 0.1-50% by weight of least one of the following: a transition metal or a lanthanide series element other than Ce. Although the passive NOX adsorbent can include Ce in an amount ranging from 0.1 to 20% by weight expressed in terms of oxide, advantages are obtained particularly in the case of low-Ce or a substantially Ce-free passive NOx adsorbent.
    Type: Grant
    Filed: April 5, 2018
    Date of Patent: December 10, 2019
    Assignees: Magnesium Elektron Ltd., University of Kentucky Research Foundation
    Inventors: Deborah Jayne Harris, David Alastair Scapens, John G. Darab, Mark Crocker, Yaying Ji
  • Patent number: 10501556
    Abstract: Methods for treating a cocaine-related disorder in an individual include administering to the individual a therapeutic amount of an antibody comprising a human immunoglobulin gamma heavy chain and a murine lambda light chain. In another embodiment, the light chain includes a human kappa light chain at least partially derived from 1B3. Other embodiments are directed toward the antibodies themselves and methods of binding the antibodies.
    Type: Grant
    Filed: August 15, 2017
    Date of Patent: December 10, 2019
    Assignees: University of Cincinnati, E. R. Squibb & Sons, L.L.C.
    Inventors: Andrew B. Norman, William J. Ball, Jr., Nils Lonberg, Denise Williams
  • Patent number: 10500275
    Abstract: An object of the present invention is to provide a novel method that is excellent in superovulation induction efficiency. Specifically, it is an object to provide a method giving superior superovulation induction efficiency as compared with conventional methods using equine chorionic gonadotropin (eCG) and human chorionic gonadotropin (hCG). The present invention provides a superovulation inducing method, comprising simultaneously administering anti-inhibin antibody and equine chorionic gonadotropin (eCG), then, administering human chorionic gonadotropin (hCG), to a female mouse.
    Type: Grant
    Filed: February 19, 2016
    Date of Patent: December 10, 2019
    Assignee: National University Corporation Kumamoto University
    Inventors: Naomi Nakagata, Toru Takeo
  • Patent number: 10500291
    Abstract: The invention relates to lipid polymeric patchy particles formed by nanoprecipitation and emulsification processes, utilizing a polymer blend including the polymer, solvent and lipid-PEGylated functional groups. More particularly, the invention relates to synthesizing particles having different or pre-selected morphologies (internal and external) and physicochemical properties. It has been found that the shear stress experienced by the polymer blend during emulsification can impart certain external and internal morphology and physicochemical properties to the resulting particles. Further, the one or more patches of the particles can be functionalized, such as, with gold nanoparticles, for use of the particles, in particular, in photoacoustic and ultrasound imaging.
    Type: Grant
    Filed: February 26, 2016
    Date of Patent: December 10, 2019
    Assignee: George Mason University
    Inventor: Carolina Salvador Morales
  • Patent number: 10502686
    Abstract: Organosilane functionalised carbon nanoparticles comprising a carbon dot bonded to an organosilane functionalization agent in a first orientation having one or more functional groups capable of binding mercury located at or proximal to a free end thereof.
    Type: Grant
    Filed: July 3, 2015
    Date of Patent: December 10, 2019
    Assignee: Griffith University
    Inventors: Qin Li, Wentai Wang
  • Patent number: 10501797
    Abstract: Whether a fetus has an aneuploidy associated with a first chromosome is detected using ratios of alleles detected in a maternal sample having a mixture of maternal and fetal DNA. DNA from the sample is enriched for target regions associated with polymorphic loci and then sequenced. Polymorphic loci (e.g., single nucleotide polymorphisms) in the target regions with fetal-specific alleles are identified on a first chromosome and on one or more reference chromosomes. A first ratio of the fetal-specific alleles and shared alleles is determined for the loci on the first chromosome. A second ratio of the fetal-specific alleles and shared alleles is determined for the loci on the reference chromosome(s). A third ratio of the first and second ratio can be compared to a cutoff to determine whether an aneuploidy is present, and whether the aneuploidy is maternally-derived or paternally-derived.
    Type: Grant
    Filed: March 21, 2016
    Date of Patent: December 10, 2019
    Assignee: The Chinese University of Hong Kong
    Inventors: Jiawei Liao, Kwan Chee Chan, Wai Kwun Rossa Chiu, Yuk Ming Dennis Lo
  • Patent number: 10505127
    Abstract: This invention discloses novel polycyclic heteroaromatic compound core structures. These compounds can be used as hosts for PHOLEDs.
    Type: Grant
    Filed: August 21, 2017
    Date of Patent: December 10, 2019
    Assignee: Universal Display Corporation
    Inventors: Alexey Borisovich Dyatkin, Bin Ma
  • Patent number: 10500086
    Abstract: An orthotic obstructive sleep apnea treatment device is provided that includes a hyoid bone attachment element disposed to attach a ferric element to a hyoid bone, where the ferric element is disposed to face along a treatment vector from the hyoid bone, and the treatment vector is oriented relative to a sagittal plane of a human. The orthotic obstructive sleep apnea treatment device further includes an external orthotic neck device having a contoured housing with a shape disposed to conform about a neck of the human subject, where the housing includes a force delivery element disposed at an exterior-front neck region of the human subject and is disposed to provide an attractive force to the ferric element along the treatment vector. A force sensor is disposed to measure a force exerted on the hyoid bone, a skin contact pressure, tissue compression between the ferric element and the force delivery element.
    Type: Grant
    Filed: May 22, 2017
    Date of Patent: December 10, 2019
    Assignee: The Regents of the University of California
    Inventors: Michael R. Harrison, Kathryn H. Rosenbluth, Dillon A. Kwiat, Eric J. Kezirian, Richard J. Fechter, Darrell Christensen
  • Patent number: 10501448
    Abstract: Various embodiments disclosed relate to aziridinated triglycerides and polymers formed therefrom. In various embodiments, the present invention provides an aziridinated triglyceride having the structure described herein. In various embodiments, the present invention provides a method of making the aziridinated triglyceride, a method of crosslinking the aziridinated triglyceride to form a polymer, the polymer formed from the aziridinated triglyceride, a triglyceride with at least one pendent unsaturated group that can be used to form the aziridinated triglyceride, and a method of making the triglyceride having at least one pendent unsaturated group.
    Type: Grant
    Filed: July 23, 2018
    Date of Patent: December 10, 2019
    Assignee: Iowa State University Research Foundation, Inc.
    Inventors: Ruqi Chen, Jason Shih-Hao Chen, Chaoqun Zhang, Michael Richard Kessler
  • Patent number: 10501508
    Abstract: A fusion chimeric protein is described herein that can assemble a functional carboxysome core, which is able to fix carbon by taking atmospheric carbon dioxide and converting it into useful carbon-containing compounds such as 3-phosphoglycerate (3-PGA).
    Type: Grant
    Filed: August 24, 2017
    Date of Patent: December 10, 2019
    Assignee: Board of Trustees of Michigan State University
    Inventors: Cheryl A. Kerfeld, Cesar R. Gonzalez
  • Patent number: 10499628
    Abstract: Dispenser devices suitable for use on unmanned aerial vehicles are described having utility for dispensing solid larvicides to difficult to reach insect habitats.
    Type: Grant
    Filed: September 9, 2016
    Date of Patent: December 10, 2019
    Assignee: Rutgers, The State University of New Jersey
    Inventors: Gregory M. Williams, Randy Gaugler
  • Patent number: 10501668
    Abstract: In one embodiment, a method for depositing metal on a polymer surface, the method includes coating the polymer surface with a binding metal to render the polymer surface solvophillic and/or hydrophilic and depositing a further metal on the binding metal-coated polymer surface.
    Type: Grant
    Filed: August 22, 2017
    Date of Patent: December 10, 2019
    Assignee: University of South Florida
    Inventors: Jaspreet Dhau, D. Yogi Goswami, Chand K. Jotshi, Elias K. Stefanakos
  • Patent number: 10500568
    Abstract: The present invention discloses a core-shell structure supported tungsten composite catalyst and a preparation method and use thereof. Most of the existing synthesis methods of the main ring of quinolone drugs have the defects of many synthesis steps, cumbersome operation, large amount of three wastes, higher costs and the like. The present invention prepares a magnetic separable core-shell supported tungsten composite catalyst, WO3/SiO2/Fe3O4, by preparing Fe3O4 colloid and SiO2/Fe3O4 composite nano-particles. This magnetic separable core-shell supported tungsten composite catalyst, WO3/SiO2/Fe3O4, is used to catalyze and synthesize quinolone compounds. The present invention provides an efficient preparation method of quinolone compounds using a catalyst which can be recovered by magnetic separation and recycled.
    Type: Grant
    Filed: December 20, 2017
    Date of Patent: December 10, 2019
    Assignees: Hangzhou Normal University, Zhejiang Benli Technology Co., Ltd.
    Inventors: Pengfei Zhang, Chao Shen, Xiaoling Li, Jun Xu, Haining Gu
  • Patent number: 10500244
    Abstract: The black eggplant skin antioxidant nanoparticles may be manufactured by extracting black eggplant skins in a solvent, spraying the black eggplant skin extracts into boiling water under ultrasonic conditions to produce a first mixture, sonicating the mixture, stirring the mixture, and drying the mixture to obtain black eggplant skin antioxidant nanoparticles. In an embodiment, the black eggplant skin may be skin of Solanum melongena. In an embodiment, the black eggplant skin nanoparticles may have improved antibacterial or antioxidant properties.
    Type: Grant
    Filed: May 10, 2019
    Date of Patent: December 10, 2019
    Assignee: King Saud University
    Inventors: Hany Mohamed Yehia, Mohamed Fekry Serag El-Din, Hatem Salama Mohamed Ali, Mohamed Saleh Alamri, Wafa Abdullah Al-Megrin, Manal Fawzy Elkhadragy, Manal Ahmed Gasmelseed Awad
  • Patent number: 10502749
    Abstract: Identified are markers whose de novo synthesis or levels in blood provide are correlative information on the status of pathology, regardless of whether or not they correlate with the status in the relevant organ. The de novo synthesis or levels in blood can be used for patient stratification and monitoring the efficacy of treatment of diseases, such as fragile X syndrome.
    Type: Grant
    Filed: June 8, 2017
    Date of Patent: December 10, 2019
    Assignee: New York University
    Inventors: Heather L. Bowling, Aditi Bhattacharya, Eric Klann
  • Patent number: 10501741
    Abstract: Provided herein are methods and compositions for inhibiting epithelial to mesenchymal transition of a cell.
    Type: Grant
    Filed: June 25, 2015
    Date of Patent: December 10, 2019
    Assignees: Cold Spring Harbor Laboratory, Rutgers, The State University of New Jersey
    Inventors: Raffaella Sordella, Serif Senturk, Luca Cartegni, Zhan Yao
  • Patent number: 10500157
    Abstract: Compositions for delivery of growth factors needed for stable Tregs and methods of use thereof are provided. In preferred embodiments, the compositions can induce, increase, or enhance a functionally robust induced CD4 Treg population (e.g., Foxp3+ Treg) in vivo or ex vivo. The compositions generally include delivery vehicles including TGF-? and IL-2. Delivery vehicles include, for example, polymeric particles, silica particles, liposomes, or multilamellar vesicles. The TGF-? and IL-2 are typically co-loaded into, attached to the surface of, and/or enclosed within the delivery vehicle into the same particle for simultaneous co-delivery to cells such as T cells. Preferably the delivery vehicles are targeted to CD4. The compositions and cells treated therewith can be used in various methods of treating, for example, inflammation, inflammatory and autoimmune diseases and disorders, and inducing or maintaining tolerance including graft and transplant tolerance.
    Type: Grant
    Filed: June 27, 2018
    Date of Patent: December 10, 2019
    Assignee: Yale University
    Inventor: Tarek M. Fahmy
  • Patent number: 10500645
    Abstract: A method of synthesizing silver nanoparticles using mint can include providing a solution including silver nitrate, providing an extract of mint, mixing the silver nitrate solution and the extract solution to form an aqueous mixture, and resting the aqueous mixture for a period of time to form the silver nanoparticles. The mint can be mint grown and harvested in Medina, Saudi Arabia.
    Type: Grant
    Filed: January 7, 2019
    Date of Patent: December 10, 2019
    Assignee: King Saud University
    Inventor: Fozeyah Saleh Almiman
  • Patent number: 10501757
    Abstract: A recombinant vector comprises simian adenovirus 43, 45, 46, 47, 48, 49 or 50 sequences and a heterologous gene under the control of regulatory sequences. A cell line which expresses simian adenovirus 43, 45, 46, 47, 48, 49 or 50 gene(s) is also disclosed. Methods of using the vectors and cell lines are provided.
    Type: Grant
    Filed: March 3, 2017
    Date of Patent: December 10, 2019
    Assignee: The Trustees of the University of Pennsylvania
    Inventors: Soumitra Roy, James M. Wilson, Luc H. Vandenberghe
  • Patent number: 10504662
    Abstract: The method of making a supercapacitor using porous activated carbon from cow dung includes converting cow dung to porous activated carbon by, in a first step, preparing the dung waste by washing and drying the dung waste, and heating the dung waste in a vacuum environment to form pre-carbonized carbon. In a second step, the pre-carbonized carbon is impregnated with phosphoric acid to form a slurry, which is dried, ground, and heated in a vacuum to between 600-900° C. to form porous activated carbon. The porous activated carbon is mixed with a binder, acetylene black, and an organic solvent to form a paste, which is dried on a conductive metal foil to form an electrode. Two such electrodes (an anode and cathode) to are coated with an electrolyte gel (e.g., aqueous potassium hydroxide) and separated by a polymer (e.g., PTFE) membrane to form the supercapacitor.
    Type: Grant
    Filed: November 8, 2018
    Date of Patent: December 10, 2019
    Assignee: King Saud University
    Inventors: Jothi Ramalingam Rajabathar, Hamad Abdullah Al-Lohedan, Judith J. Vijaya, M. Sivachidambaram